NewEdge Advisors’s SAB Biotherapeutics, Inc. Warrant SABSW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $35 | Hold |
1,072
| – | – | ﹤0.01% | 3945 |
|
|
2025
Q1 | $28 | Hold |
1,072
| – | – | ﹤0.01% | 3877 |
|
|
2024
Q4 | $80 | Hold |
1,072
| – | – | ﹤0.01% | 3795 |
|
|
2024
Q3 | $39 | Hold |
1,072
| – | – | ﹤0.01% | 3753 |
|
|
2024
Q2 | $50 | Hold |
1,072
| – | – | ﹤0.01% | 3714 |
|
|
2024
Q1 | $42 | Hold |
1,072
| – | – | ﹤0.01% | 3741 |
|
|
2023
Q4 | $32 | Hold |
1,072
| – | – | ﹤0.01% | 3687 |
|
|
2023
Q3 | $75 | Hold |
1,072
| – | – | ﹤0.01% | 3378 |
|
|
2023
Q2 | $112 | Hold |
1,072
| – | – | ﹤0.01% | 3419 |
|
|
2023
Q1 | $39 | Hold |
1,072
| – | – | ﹤0.01% | 3368 |
|
|
2022
Q4 | $0 | Buy |
+1,072
| New | – | ﹤0.01% | 4187 |
|